drugset / Trial / NCT00019734
Vaccine Therapy in Treating Patients With Metastatic Melanoma
RandomizedTreatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of vaccine therapy with and without interleukin-2 in treating patients who have metastatic melanoma that has not responded to previous treatment.
Timeline
- Start
- 1999-07
- Primary completion
- —
- Completion
- 2003-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | aldesleukin | Protein / enzyme biologic | — | Subcutaneous |
| Subject | fowlpox virus vaccine vector | Vaccine | — | Intramuscular |
| Subject | vaccinia-tyrosinase vaccine | Vaccine | — | Intramuscular |